POINT Biopharma Global Inc

NASDAQ:PNT   11:08:38 AM EDT
-0.46 (-5.89%)

NorthStar Medical, Point Biopharma Announce Supply Agreement For Therapeutic Medical Radioisotope Actinium-225

Published: 09/08/2021 13:03 GMT
POINT Biopharma Global Inc (PNT) - Northstar Medical Radioisotopes and Point Biopharma Announce Supply Agreement for Therapeutic Medical Radioisotope Actinium-225.
Point Biopharma Global Inc - Northstar Will Provide Point With Its Electron Accelerator-produced Ac-225.
Point Biopharma Global Inc - Point Will Use Northstar's Ac-225 in Investigational Studies of Pnt2001.